Each fall in Chicago, top pharmaceutical patent litigators for brand name and generic drug companies gather to receive the latest updates on Hatch-Waxman litigation and engage in valuable peer networking. As the industry grapples with significant patent losses and evolving laws and regulations, this conference has never been more essential or timely.
Benchmark and Network Over Breakfast
Meet with top Brand and Pharmaceutical Manufacturers at ACI’s In House Think Tank. Discuss the impact of the latest Hatch-Waxman developments and share best practices for managing legal costs, talent and communication with outside counsel.
Move the Dial on DEI in Life Sciences IP
Develop a deeper understanding of why DEI should matter to your organization, current gaps in the Life Sciences IP legal landscape and the practical steps both in house and outside counsel can take to promote diversity.
Garner Global Perspectives on Patent Law and Supply Chain Dynamics
Put patent strategies in play with the bigger picture in mind. Hear U.S. European and Indian perspectives on matters of concern for brand and generic drug makers.
Co-Chairs
Aaron F. Barkoff, Ph.D.
Associate Vice President – General Patent Counsel, IP Litigation
Eli Lilly, and Company
April E. Weisbruch
Partner
McDermott Will & Emery LLP
Kevin Zive
Vice President, General Counsel, and Head of Global Intellectual Property
Apotex Inc.
SPECIAL PRESENTATION BY U.S. MAGISTRATE JUDGES
Honorable Tonianne J.Bongiovanni
U.S. M.J.
District of New Jersey
Honorable Christopher J. Burke
U.S. M.J.
District of Delaware
Honorable Sherry R. Fallon
U.S. M.J.
District of Delaware
USPTO PTAB
Honorable Jacqueline Bonilla
Deputy Chief Administrative Patent Judge; Senior Legal Advisor, Under Secretary of Commerce for Intellectual Property and Director
USPTO
FTC
Tim Kamal-Grayson
Attorney
Federal Trade Commission (FTC)
About the Conference
Hear from PhRMA, BIO and AmCham on the current policy state of play for small molecules
Meet over a dozen leading senior in-house patent counsel from brands and generics
Learn from a Chambers-ranked “who’s who” of the Hatch-Waxman bar from New York, DC, and Chicago
Featuring Key Topics
Spotlight on Chevron Overturned in Loper V. Raimondo
Post-Cellect Strategy Session on new Paragraph IV OTDP, PTA concerns
§112 Think Tank
Drill down on the Use of Clinical Trials as Prior Art
Focus on Patent Rights and Supply Chain Dynamics
Fireside Chat Future FDA Activity Affecting Small Molecules
Sponsorship Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
WHO YOU WILL MEET
Patent attorneys and litigators (in-house & law firms) who represent:
- Brand name pharmaceutical companies
- Generic pharmaceutical companies
- Biopharmaceutical companies